malignant hematopathy 恶性血液病
patients with hematopathy 血液病患者
Children with hematopathy 血液病患儿
inpatients with hematopathy 血液病病人
drugs used for hematopathy 血液系统用药
patients with benign hematopathy 良性血液病
difficult and complicated hematopathy 疑难血液病
malignant and nonmalignant hematopathy 恶性和非恶性血液病
Conclusion Linezolid has high safety and excellent clinical efficacy in the treatment of gram-positive bacteria infection in malignant hematopathy patients.
结论利奈唑胺用于恶性血液病患者革兰阳性菌感染的治疗有较好临床疗效,且副反应小,安全性好。
参考来源 - 利奈唑胺治疗恶性血液病并革兰阳性菌感染18例临床研究·2,447,543篇论文数据，部分数据来源于NoteExpress
Objective to evaluate the feasibility and effect of the treatment of hematopathy by laparoscopy plus small incision splenectomy.
目的探讨腹腔镜辅助小切口脾切除治疗血液系统疾病的可行性及效果。
Objective to evaluate the indications, complications, and effect of splenectomy performed in patients suffering from hematopathy.
目的总结血液病患者脾切除术的手术指征、并发症和治疗效果。
Objective to explore P53 expression on malignant hematopathy especially acute leukemia patients and its relationship with chemotherapeutic tolerant.
目的研究恶性血液病尤其是急性白血病患者P 53表达水平及其与化疗耐受的关系。
应用推荐